EA200700760A1 - MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES - Google Patents
MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASESInfo
- Publication number
- EA200700760A1 EA200700760A1 EA200700760A EA200700760A EA200700760A1 EA 200700760 A1 EA200700760 A1 EA 200700760A1 EA 200700760 A EA200700760 A EA 200700760A EA 200700760 A EA200700760 A EA 200700760A EA 200700760 A1 EA200700760 A1 EA 200700760A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prostate gland
- treatment
- agent
- proposed
- ratio
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к медицине и фармацевтической промышленности, в частности к созданию новых лекарственных средств для лечения заболеваний мочеполовой системы. Предлагаемое средство для лечения заболеваний предстательной железы, выполненное в виде суппозитория, содержащее комплекс биорегуляторных пептидов предстательной железы крупного рогатого скота в форме порошка с содержанием водорастворимых пептидов не менее 20%, антимикробное средство, представляющее собой антибиотик, или противовирусное средство, или противопротозойное средство, или смесь антибиотика и противопротозойного средства, взятых в соотношении 1:1, или смесь противовирусного и противопротозойного средств, взятых в соотношении 1:1, и основу, при следующем соотношении компонентов, г на одну свечу: комплекс биорегуляторных пептидов предстательной железы крупного рогатого скота - 0,05-0,4, антимикробное средство - не более 0,7, основа - достаточное количество для получения суппозитория массой 2,15-2,35 г. В качестве основы для получения предлагаемого средства используется любая фармацевтически приемлемая основа, например витепсол, твердый жир, масло какао. Как показали проведенные исследования, предлагаемое средство в виде суппозиториев обладает высоким уровнем органотропной активности и высоким уровнем антимикробного действия.The invention relates to medicine and the pharmaceutical industry, in particular to the creation of new medicines for the treatment of diseases of the urogenital system. The proposed remedy for the treatment of diseases of the prostate gland, made in the form of a suppository, containing a complex of bioregulatory peptides of the prostate gland of cattle in the form of a powder with a content of water-soluble peptides of at least 20%, an antimicrobial agent, which is an antibiotic, or antiviral agent, or antiprotozoan, or a mixture of antibiotic and antiprotozoal agents, taken in a 1: 1 ratio, or a mixture of antiviral and antiprotozoa drugs, taken in a ratio ii 1: 1, and the basis, in the following ratio of components, g per candle: complex of bioregulatory peptides of the prostate gland of cattle - 0.05-0.4, antimicrobial agent - not more than 0.7, base - enough for suppository weighing 2.15-2.35 g. Any pharmaceutically acceptable base is used as the basis for obtaining the proposed agent, for example, witepsol, tallow, cocoa butter. As studies have shown, the proposed tool in the form of suppositories has a high level of organotropic activity and a high level of antimicrobial action.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200700760A EA200700760A1 (en) | 2007-04-27 | 2007-04-27 | MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200700760A EA200700760A1 (en) | 2007-04-27 | 2007-04-27 | MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES |
Publications (2)
Publication Number | Publication Date |
---|---|
EA010427B1 EA010427B1 (en) | 2008-08-29 |
EA200700760A1 true EA200700760A1 (en) | 2008-08-29 |
Family
ID=40849032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200700760A EA200700760A1 (en) | 2007-04-27 | 2007-04-27 | MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA200700760A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642079B2 (en) * | 2004-02-23 | 2014-02-04 | Hormos Medical Corporation | Solid formulations of ospemifene |
RU2640931C1 (en) * | 2017-03-23 | 2018-01-12 | Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" | Rectal suppositories for prostate treatment containing lysyl-glutamyl-aspartyl-proline tetrapeptide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2112504C1 (en) * | 1996-12-24 | 1998-06-10 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Agent "vitaprost" for prostate gland disease treatment |
RU2160114C1 (en) * | 1999-10-06 | 2000-12-10 | Государственное унитарное предприятие "Иммунопрепарат" | Rectal means for treating chronic prostatitis |
KR100438416B1 (en) * | 2001-09-19 | 2004-07-02 | 학교법인조선대학교 | Novel peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof |
HU0104790D0 (en) * | 2001-11-08 | 2002-01-28 | Human Rt | Pharmaceutical combinations for topical application |
RU2278675C1 (en) * | 2005-01-17 | 2006-06-27 | Юрий Борисович Иванов | Antibacterial agent and pharmaceutical composition comprising effective amount of antibacterial agent |
-
2007
- 2007-04-27 EA EA200700760A patent/EA200700760A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA010427B1 (en) | 2008-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200619220A (en) | New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5, 6, 7, 8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament | |
TW200510429A (en) | Heterocyclic MCHR1 antagonists | |
IL176007A0 (en) | Antibodies specific to c35 and pharmaceutical compositions containing the same | |
UA83659C2 (en) | P2x7 receptor antagonists and their use, pharmaceutical composition based thereon, process for the preparation thereof (variants) | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
IL187328A (en) | N-methyl-2-fluoro-{4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]}benzamide, pharmaceutical compositions comprising the same and uses thereof in the manufacture of medicaments | |
HRP20050735B1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
TNSN07005A1 (en) | TETRAPEPTITIIC ANALOGS | |
MXPA05010682A (en) | Novel compounds. | |
TW200634003A (en) | Chemical compounds | |
GEP20084466B (en) | Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
TW200519075A (en) | Novel compounds | |
GB0625648D0 (en) | Compounds | |
UA104988C2 (en) | Novel pyrone-indole derivatives and process for their preparation | |
TW200745122A (en) | New compounds I | |
TW200738659A (en) | Novel compounds | |
PL2018170T3 (en) | Medication against breast cancer | |
MXPA05011076A (en) | Chemical compounds. | |
BRPI0518789A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet | |
UA86441C2 (en) | (2-hydroxyethyl)trimethylammonium thiooctate (choline thioctate), having hepatoprotective, hypoamoniemic and detoxic action, method for production thereof and pharmaceutical compositions based on it | |
BRPI0518786A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet | |
TW200505452A (en) | Chemical compounds | |
PL1831239T3 (en) | A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid lambda-lactone and key-intermediates for this process | |
TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
EA200700760A1 (en) | MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |
|
TC4A | Change in name of a patent proprietor in a eurasian patent | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |